Breakthrough T1D
@BreakthroughT1D • 62,864 subscribers
As we drive toward curing type 1 diabetes, we help make everyday life better for the people who face it. We are Breakthrough T1D.
Videos
Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes. This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase. Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring. Learn more here:
Breakthrough T1D42,413 Aufrufe • vor 1 Jahr
Same mission, New name. Breakthrough T1D (formerly JDRF) is the world leader in T1D research, advocacy, and community support. Our new brand reflects our bold vision for a world without T1D. We are accelerating breakthroughs and building a movement for change. #BreakthroughT1D
Breakthrough T1D23,740 Aufrufe • vor 2 Jahren
Earlier today at the ADA Scientific Sessions, Sana Biotechnology gave an exciting 6-month update on the first person who received transplanted donor-derived pancreatic islet cells modified with hypo-immune (HIP) technology, a cell therapy that does NOT require immunosuppression. Breakthrough T1D’s Vice President of Research, Esther Latres, Ph.D., gives an update on this incredibly exciting step toward cures for type 1 diabetes (T1D).
Breakthrough T1D14,103 Aufrufe • vor 1 Jahr
Keine weiteren Inhalte verfügbar